Advanced Diffusion Imaging in Renal Cancer Patients

• Status: Recruiting
• Trial end date: 2026-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: NYU Langone Health
• Collaborator: National Institutes of Health (NIH)
• Treatments: Pentetic Acid

Criteria

Inclusion Criteria:

• Renal mass patients scheduled for laparoscopic partial nephrectomy.

• eGFR above 30 ml/min/m2.

• Ages 21 to 85

• Must be willing and able to provide consent.

Exclusion Criteria:

• All metal implants and dental implants that have ferromagnetic properties and are unsafe at 3.0 T.

• Pregnant women are not eligible for participating in this study.

• Acute claustrophobia